BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 1181667)

  • 21. Pancreatic and gastric somatostatin release in response to intragastric and intraduodenal nutrients and HCl in the dog.
    Schusdziarra V; Harris V; Conlon JM; Arimura A; Unger R
    J Clin Invest; 1978 Sep; 62(3):509-18. PubMed ID: 690183
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of phenformin upon the plasma pancreatic and gut glucagon-like immunoreactivity in diabetics.
    Czyzyk A; Heding LG; Malczewski B; Miedzinska E
    Diabetologia; 1975 Apr; 11(2):129-33. PubMed ID: 168107
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influence of somatostatin on carbohydrate disposal and absorption in diabetes mellitus.
    Wahren J
    Lancet; 1976 Dec; 2(7997):1213-6. PubMed ID: 63040
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Somatostatin stimulates glucagon secretion in ducks.
    Strosser MT; Cohen L; Harvey S; Mialhe P
    Diabetologia; 1980 Apr; 18(4):319-22. PubMed ID: 6106614
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Decrease in blood glucose and release of gut glucagon-like immunoreactive materials by bombesin infusion in the dog.
    Matsuyama T; Namba M; Nonaka K; Tarui S; Tanaka R; Shima K
    Endocrinol Jpn; 1980 Dec; 27 Suppl 1():115-9. PubMed ID: 7014201
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of somatostatin on glucose homeostasis in conscious long-fasted dogs.
    Stevenson RW; Steiner KE; Hendrick GK; Cherrington AD
    Am J Physiol; 1987 Oct; 253(4 Pt 1):E435-42. PubMed ID: 2889363
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of substance P and other peptides on the release of somatostatin, insulin, and glucagon in vitro.
    Hermansen K
    Endocrinology; 1980 Jul; 107(1):256-61. PubMed ID: 6155261
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of somatostatin on fasting and glucose-stimulated gastric inhibitory polypeptide release in man.
    Salera M; Pironi L; Giacomoni P; Venturi S; Capelli M; Miglioli M; Barbara L
    Digestion; 1982; 24(2):126-32. PubMed ID: 6127273
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Modulatory effect of glucose, amino acids, and secretin on CCK-8-induced somatostatin and pancreatic polypeptide release in dogs.
    Schusdziarra V; Lenz N; Schick R; Maier V
    Diabetes; 1986 May; 35(5):523-9. PubMed ID: 2869995
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of intestinal glucagon-like immunoreactivity (GLI) secretion by somatostatin in man.
    Marco J; Hedo JA; Villaneuva ML
    J Clin Endocrinol Metab; 1977 Apr; 44(4):695-8. PubMed ID: 849979
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of somatostatin on nonesterified fatty acid levels modifies glucose homeostasis during fasting.
    Hendrick GK; Frizzell RT; Cherrington AD
    Am J Physiol; 1987 Oct; 253(4 Pt 1):E443-52. PubMed ID: 2889364
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of phentolamine on the somatostatin-induced inhibition of glucagon and insulin secretion.
    Kaneto A; Kajinuma H; Kaneko T; Kosaka K
    Metabolism; 1978 Aug; 27(8):901-10. PubMed ID: 209286
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chromatographic pattern of gut glucagon-like immunoreactivity (GLI) in plasma before and during glucose absorption.
    Valverde I; Ghiglione M; Matesanz R; Casado S
    Horm Metab Res; 1979 May; 11(5):343-6. PubMed ID: 478429
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evidence for a role of splanchnic somatostatin in the homeostasis of ingested nutrients.
    Schusdziarra V; Harris V; Arimura A; Unger RH
    Endocrinology; 1979 Jun; 104(6):1705-8. PubMed ID: 446390
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Plasma glucagon-like immunoreactivity (GLI) in dogs.
    Oneda A; Horigome K; Yanbe A; Ishii S; Itabashi H
    Tohoku J Exp Med; 1975 Apr; 115(4):337-43. PubMed ID: 1145615
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of fast duration on disposition of an intraduodenal glucose load in the conscious dog.
    Galassetti P; Hamilton KS; Gibbons FK; Bracy DP; Lacy DB; Cherrington AD; Wasserman DH
    Am J Physiol; 1999 Mar; 276(3):E543-52. PubMed ID: 10070022
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intraduodenal guar attenuates the fall in blood pressure induced by glucose in healthy older adults.
    O'Donovan D; Feinle-Bisset C; Chong C; Cameron A; Tonkin A; Wishart J; Horowitz M; Jones KL
    J Gerontol A Biol Sci Med Sci; 2005 Jul; 60(7):940-6. PubMed ID: 16079222
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of somatostatin and a glucagon-specific analog on glucose homeostasis during arginine infusion.
    Lien EL
    Metabolism; 1978 Sep; 27(9):1095-100. PubMed ID: 682972
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of somatostatin on neurotensin-induced glucagon release and hyperglycemia.
    Ukai M; Inoue I; Itatsu T
    Endocrinology; 1977 May; 100(5):1284-6. PubMed ID: 849724
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effects of somatostatin on hormonal and metabolic responses in chronic pancreatitis.
    Botha JL; Vinik AI; le Roith D; Child PT; Jackson WP
    S Afr Med J; 1977 Jun; 51(24):872-5. PubMed ID: 897837
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.